BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3124129)

  • 1. Apolipoprotein assays for the diagnosis of hyperlipidemias.
    Rosseneu M; Bury J
    Prog Clin Biol Res; 1988; 255():143-54. PubMed ID: 3124129
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of apolipoprotein levels in clinical practice.
    Grundy SM; Vega GL
    Arch Intern Med; 1990 Aug; 150(8):1579-82. PubMed ID: 2116784
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease.
    Sniderman AD
    Can J Cardiol; 1988 Jul; 4 Suppl A():24A-30A. PubMed ID: 3141025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of serum apolipoproteins A1 and B by immunoturbidimetry using the Cobas-Bio centrifugal analyzer. Influence of hyperlipemia].
    Hachem H; Raynal G; Favre G; Hamza M; Canal P; Soula G
    Ann Biol Clin (Paris); 1985; 43(6):885-90. PubMed ID: 3938627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid and apolipoprotein levels in patients with ischaemic heart disease. A comparative study in Plzen and Moscow.
    Steinerová A; Perova NV; Metel'skaya VA; Topolcan O; Karlícek V; Polívková V
    Cor Vasa; 1989; 31(4):257-63. PubMed ID: 2509134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a).
    Genest JJ; McNamara JR; Ordovas JM; Martin-Munley S; Jenner JL; Millar J; Salem DN; Schaefer EJ
    Am J Cardiol; 1990 Mar; 65(9):677-9. PubMed ID: 2106773
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standardization of the immunochemical detection of apolipoprotein A-I and B].
    Dati F; Marcovina SM; Albers JJ
    Behring Inst Mitt; 1990 Oct; (86):116-28. PubMed ID: 2123624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reference values of serum apolipoprotein A-I and B].
    Li JZ; Wang JJ
    Zhonghua Yi Xue Za Zhi; 1986 Sep; 66(9):531-3, 576. PubMed ID: 3098374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of 6 serum pools in standardization of the determination of apolipoproteins AI and B in the human serum].
    Beucler I; Caces E; Camare R; Dachet C; Fruchart JC; Gambert P; Girault A; Leglise D; Legrand A; Mainard F
    Ann Biol Clin (Paris); 1990; 48(7):443-7. PubMed ID: 2126170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of blood apolipoproteins A-I and B in persons with normal blood lipids and persons with hyperlipidemia and proven atherosclerosis].
    Choluj B; Votruba T; Klestincová J; Sedlák F; Matyska L; Hrudková M
    Vnitr Lek; 1985 May; 31(5):464-8. PubMed ID: 3927589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease.
    Reinhart RA; Gani K; Arndt MR; Broste SK
    Arch Intern Med; 1990 Aug; 150(8):1629-33. PubMed ID: 2116785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
    Luoma PV; Marniemi J; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.
    Marcovina S; Packard CJ
    J Intern Med; 2006 May; 259(5):437-46. PubMed ID: 16629849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ischemic heart disease and plasma apoproteins B and A-1].
    Kurdanov KhA; Metel'skaia VA; Polesskiĭ VA; Matveeva LS; Perova NV
    Ter Arkh; 1984; 56(12):17-9. PubMed ID: 6441299
    [No Abstract]   [Full Text] [Related]  

  • 16. Apolipoprotein A-I and apolipoprotein B in survivors of myocardial infarction.
    Karira K; Baseer A
    J Pak Med Assoc; 1987 Feb; 37(2):44-7. PubMed ID: 3106663
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: the Stanford Five City Project.
    Gardner CD; Tribble DL; Young DR; Ahn D; Fortmann SP
    Prev Med; 2000 Oct; 31(4):346-56. PubMed ID: 11006059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project.
    Gardner CD; Tribble DL; Young DR; Ahn D; Fortmann SP
    Prev Med; 2000 Oct; 31(4):335-45. PubMed ID: 11006058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of LDL-cholesterol results calculated by using apolipoproteins A1, B or HDL-cholesterol for classification of non-chylomicron dyslipidemias].
    Szmidt-Adjid V; Campier A; Pileire B
    Ann Biol Clin (Paris); 1999 May; 57(3):345-50. PubMed ID: 10377488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.